The present invention includes an apparatus for transdermal treatments comprising: an openable enclosure for a subject in communication with three or more sources of treatment modalities selected from: a source of ozone; a source of steam, a source of CO.sub.2/Carbonic Acid; a source of Far Infrared; and a source of pulsed electromagnetic fields (PEMF), wherein each of the three or more sources is in communication with an interior of the openable enclosure to treat the subject transdermally.

The present invention includes an apparatus for transdermal treatments comprising: an openable enclosure for a subject in communication with three or more sources of treatment modalities selected from: a source of ozone; a source of steam, a source of CO.sub.2/Carbonic Acid; a source of Far Infrared; and a source of pulsed electromagnetic fields (PEMF), wherein each of the three or more sources is in communication with an interior of the openable enclosure to treat the subject transdermally.

A therapeutic device for treating one or more conditions associated with a user's nasal cavities, sinuses, and/or ear canals includes a housing having an opening, an acoustic vibrator within the housing that is operable to provide an acoustic vibration to the user, a fan within the housing that is operable to provide a pressure to the user and a power supply that provides power to the acoustic vibrator and the fan. A mask is connected to the housing at the opening and includes a nasal interface appliable around the nose of the user, a nasal chamber in which the user's nostrils are located and an aperture through which the fan delivers the pressure.

A medical treatment system including a treatment chamber, a source of an aqueous mist containing a medication, a source of an oxygen-enriched gas, and a control system adapted to alternately surround a human body part with a mist containing a medication and the oxygen enriched gas, which can be used to treat various skin disorders including infected lesions, bacterial infections such as acne (i.e. Propionibacterium acnes), fungal infections such as Athlete's foot (i.e. fungal genus Trichophyton), conditions associated with hair loss including alopecia as well as ulcerations and frostbite resulting from poor circulation. A method of treating skin disorders is also disclosed, that includes providing a mist containing a medication and enriched oxygen gas to the site being treated as well as providing oxygen to the patient during treatment.

The invention relates to a treatment apparatus comprising an envelope that can be placed on or around a body part of a person such that the envelope has a positioning area (Z) for said body part of the person, the envelope being provided with an inlet (8) for a gaseous medium and an outlet for discharging the gaseous medium present in the envelope. According to the invention, the apparatus comprises a control system (11) for controlling the flow of the gaseous medium in order to direct the gaseous medium entering the envelope via the inlet (8) outside the positioning area (Z), and to homogenise the gaseous medium present in the envelope.

A medical treatment system including a treatment chamber, a source of an aqueous mist containing a medication, a source of an oxygen-enriched gas, and a control system adapted to alternately surround a human body part with a mist containing a medication and the oxygen enriched gas, which can be used to treat various skin disorders including infected lesions, bacterial infections such as acne (i.e. Proplanibacterium acnes), fungal infections such as Athelete's foot (i.e. fungal genus Trichophyton), conditions associated with hair loss including alopecia as well as ulcerations and frostbite resulting form poor circulation. A method of treating skin disorders is also disclosed, that includes providing a mist containing a medication and enriched oxygen gas to the site being treated its well as providing oxygen to the patient during treatment.

A portable, personal therapy chamber for provision of infrared radiation therapy. The therapy chamber includes a pair of telescopically positionable cabins that are lightweight and easily portable by a single user. The therapy chamber is configured for use by a single person lying generally prone on a surface. The cabins are disposed to overlie the user and include a plurality of infrared radiation elements that direct infrared energy toward the user's body. When using the therapy chamber, the user's head extends from an open end of the cabin. A facial treatment fixture is integrated with the cabin to be extendable longitudinally from a terminal end thereof and to overlie the user's face/head. The therapy chamber can be configured to provide mild hyperbaric oxygen therapy in addition to infrared therapy.

An apparatus to maintain an environment over an anterior surface of a patient eye can include an enclosure sized and shaped to be seated about the patient eye to form a cavity within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.

Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.

An apparatus (100) to maintain an environment over an anterior surface of a patient eye can include an enclosure (110) sized and shaped to be seated about the patient eye to form a cavity (112) within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator (1209) in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.